Patients
Physicians
Sponsors
Oncologists
About Us
News
ENG
Last updated 5 months ago
Share
GAE Using Embosphere Microspheres vs Corticosteroid Injections for Treatment of Symptomatic Knee OA (MOTION)
264 patients around the world
Available in
Brazil, United States
This study is an IDE study. It is an RCT comparing GAE to steroid injection in the knee to treat knee osteoarthritis.
Merit Medical Systems, Inc.
2
Research sites
264
Patients around the world
This study is for people with
Osteoarthritis
Requirements for the patient
From 21 Years
All Gender
Medical requirements
Inclusion criteria
Provides written informed consent.
Age ≥21 years.
Mild to severe knee pain, defined as a numerical rating scale (NRS) score of ≥4 out of 10.
Pain refractory to conservative therapies for at least 90 days prior to enrollment/randomization.
Kellgren-Lawrence grade 1, 2, 3 or 4.
Exclusion criteria
Planned major surgical or endovascular procedures ≤ 30 days after the index procedure.
Advanced atherosclerosis.
Known history of rheumatoid or infectious arthritis.
Prior knee replacement surgery of the target knee.
Sites
Hospital de Clínicas de Passo Fundo
Consult
View site
R. Uruguai, 590 - Centro, Passo Fundo - RS, 99010-110, Brazil
View site
Consult
Hospital das Clínicas da Faculdade de Medicina da São Paulo - USP
Consult
View site
Rua Dr. Ovídio Pires de Campos 785 - Estado de São Paulo 05403-000
View site
Consult
See details
Contact us
Contact us
Study
MOTION
Sponsor
Merit Medical Systems, Inc.
Conditions
Osteoarthritis
Requirements
From 21 Years
All Gender
Unique study ID
clinicaltrials.gov
NCT05818150
About us
Our mission
Our team
Partners
FAQs
Medical news
Latest news
Studies
Interviews
Testimonials
Products
UEPM Onco
UEPM Physicians
Links
Downloads
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent